BTMD [NASD]
biote Corp.
Index- P/E10.22 EPS (ttm)0.41 Insider Own21.90% Shs Outstand39.69M Perf Week1.81%
Market Cap265.05M Forward P/E7.81 EPS next Y0.54 Insider Trans0.00% Shs Float31.64M Perf Month-1.65%
Income16.20M PEG- EPS next Q0.14 Inst Own22.60% Short Float / Ratio0.13% / 1.35 Perf Quarter-5.00%
Sales158.01M P/S1.68 EPS this Y- Inst Trans8.54% Short Interest0.04M Perf Half Y-28.91%
Book/sh7.46 P/B0.56 EPS next Y-70.77% ROA3.50% Target Price10.33 Perf Year-57.13%
Cash/sh0.00 P/C2650.54 EPS next 5Y- ROE3.80% 52W Range2.00 - 10.52 Perf YTD-57.35%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-60.29% Beta-
Dividend %- Quick Ratio0.10 Sales past 5Y- Gross Margin- 52W Low109.00% ATR0.25
Employees- Current Ratio0.10 Sales Q/Q18.00% Oper. Margin- RSI (14)53.79 Volatility3.96% 7.07%
OptionableNo Debt/Eq0.00 EPS Q/Q129.80% Profit Margin- Rel Volume1.46 Prev Close4.07
ShortableYes LT Debt/Eq0.00 EarningsNov 08 AMC Payout0.00% Avg Volume29.56K Price4.18
Recom2.00 SMA204.30% SMA50-0.86% SMA200-32.67% Volume43,182 Change2.58%
Jun-24-22Initiated Cowen Outperform $11
Jun-23-22Initiated ROTH Capital Buy $9
Nov-10-22 08:30AM
Nov-08-22 04:15PM
Nov-07-22 09:15AM
Oct-31-22 08:30AM
Oct-10-22 07:45AM
08:30AM Loading…
Sep-07-22 08:30AM
08:30AM
Aug-25-22 04:05PM
Aug-24-22 08:30AM
Aug-15-22 04:56PM
Aug-09-22 04:15PM
Jul-20-22 11:00AM
Jul-18-22 10:24AM
Jun-16-22 08:30AM
Jun-06-22 04:05PM
08:16AM Loading…
08:16AM
Jun-03-22 08:59AM
May-26-22 04:05PM
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Weber Teresa SueChief Executive OfficerSep 15Option Exercise0.0085,040085,040Sep 19 04:30 PM